Critics worry that pharmaceutical companies will attempt to classify some products as herbal supplements instead of drugs to skirt the rigorous process required to bring a drug to market.
Banning over-the-counter sales of ephedrine would hurt consumers and independent business distributors, while allowing larger drug companies to profit, said Phillip Sindler of the Dallas-based Wellness International Network, which sells dietary supplements, including the stimulant.
